“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much ...

However, as Jabbour notes: “Although SGLT2 inhibitors also lead to weight loss, we do not know whether the loss of calories in the form of urinary glucose will lead to a compensatory increase in ...